AZ Family, October 18, 2019. As the FDA considers issuing stronger warnings on breast implants Dr. Diana Zuckerman explains the flaws in the original clinical trials.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Massive Marketing Muscle Pushes 3D Mammograms, Despite No Evidence They Save More Lives, Investigation Shows
An investigation shows that while 3D mammograms are marketed with claims that they are better for detecting breast cancer, research has not proven they save more lives or find more deadly cancers than 2D mammograms. The report also raises concerns about hospitals and manufacturers promoting expensive 3D tests without enough scientific evidence to back up the claims.
Read More »Parents Demand Answers on Playground Lead in DC
WUSA-TV, October 2, 2019. Local parents attended a “Community Forum on the Safety of Playgrounds and Artificial Turf Fields in D.C.,” sponsored by the Park View UNC and D.C. Safe Healthy Playing Fields on Wednesday.
Read More »Some textured implants have a cancer risk. Here’s why women are told not to remove them
WJLA, September 16, 2019. Should women with textured #breastimplants have them removed even if they don’t have lymphoma symptoms? We tell ABC7 not necessarily.
Read More »For Children With Peanut Allergies, F.D.A. Experts Recommend a New Treatment
The New York Times, September 13, 2019. About 1.2 million American children have peanut allergies. A new drug, Palforzia, does not cure the condition, but it can blunt life-threatening reactions.
Read More »